Synflix Pharmaceutical Private Limited

Synflix Pharmaceutical Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials and compliance.
CIN U74999TN2018PTC120841 Incorporated 15 February 2018 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹63.52 Lakh
▲ 139.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹45 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
8 yrs
Est. 2018
Last financials
Mar 2025
Balance sheet date

About Synflix Pharmaceutical Private Limited

Data last updated: 11 February 2026

Synflix Pharmaceutical Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 15 February 2018, the company has been in operation for over 8 years.

Registered with ROC Chennai under CIN U74999TN2018PTC120841.

Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹45 Lakh. It is led by directors Kannan Sudha and Arunachalam Lakshmi.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 99 Sidco Industrial Estate Vichoor, Chennai, Tamil Nadu, India – 600103.

As per the financials filed for FY 2025, the company reported a revenue of ₹63.52 Lakh, a growth of 139% compared to the previous year.

The company is associated with 1 brand - Synflix Pharma.

For more details, the company can be reached via its website synflixpharma.com.

Company Details of Synflix Pharmaceutical Private Limited
CIN U74999TN2018PTC120841
Registration Number 120841
Incorporation Date 15 February 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No. 99 Sidco Industrial Estate Vichoor, Chennai, Tamil Nadu, India – 600103
  • Industry
    Pharma, Pharma Contract R&D
Company report
Synflix Pharmaceutical Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Synflix Pharmaceutical Private Limited report

Financials, compliance, directors, charges, ownership and filings for Synflix Pharmaceutical Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Synflix Pharmaceutical Private Limited

Synflix Pharmaceutical Private Limited operates one associated brand: Synflix Pharma. These brands represent Synflix Pharmaceutical Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Synflix Pharma is a CDMO specializing in the manufacturing of API intermediates for the biopharma sector. synflixpharma.com

Competitors & Alternatives of Synflix Pharmaceutical Private Limited

Brands and companies operating in the same space as Synflix Pharmaceutical Private Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.

Competitor Description Location Founded
Inventys Inventys Actives, advanced intermediates, and specialty chemicals are custom manufactured. Mumbai, India, India 2005
Viyash Viyash APIs and intermediates are manufactured by Viyash as a CDMO. Hyderabad, India, India 2019
Blue Jet Healthcare Blue Jet Healthcare CDMO focused on manufacturing, supplier, and development of intermediates & APIs Mumbai, India, India 1969
Ami organics Ami organics Advanced API intermediates are manufactured for pharmaceutical use. Surat, India, India 2007
Aparna Pharmaceuticals Aparna Pharmaceuticals API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. Hyderabad, India, India 2008
HuiSheng Biotech Pharmaceutical HuiSheng Biotech Pharmaceutical APIs, intermediates, and finished dosage forms are manufactured. Hangzhou, China, China 2004
DUDE CHEM DUDE CHEM CDMO focused on manufacturing of APIs and intermediates Berlin, Germany, Germany 2019
Enanti Labs Enanti Labs Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. Hyderabad, India, India 2007
Hindys Lab Hindys Lab Manufactures and exports pharmaceutical intermediates for global markets. Hyderabad, India, India 2007

Business Activity of Synflix Pharmaceutical Private Limited

Synflix Pharmaceutical Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Synflix Pharmaceutical Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Synflix Pharmaceutical Private Limited

Synflix Pharmaceutical Private Limited is audited by RAGHAVI & CO for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
RAGHAVI & CO Locked Locked Locked
Premium access

Complete auditor history for Synflix Pharmaceutical Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Synflix Pharmaceutical Private Limited

Synflix Pharmaceutical Private Limited is currently managed by 2 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Kannan Sudha Director 15 Feb 2018 8 Years 6 Months Current
Arunachalam Lakshmi Director 15 Feb 2018 8 Years 6 Months Current

Financials of Synflix Pharmaceutical Private Limited FY 2025 filings available

Synflix Pharmaceutical Private Limited reported revenue of ₹63.52 Lakh (up 139.00% YoY) for FY 2025.

Revenue · FY 2025
₹63.52 Lakh ▲ 139.00%
Premium access

Ten-year financial statements for Synflix Pharmaceutical Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Synflix Pharmaceutical Private Limited

Premium access

Shareholding and ownership data for Synflix Pharmaceutical Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Synflix Pharmaceutical Private Limited

Synflix Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Synflix Pharmaceutical Private Limited

View historical data on people associated with Synflix Pharmaceutical Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Synflix Pharmaceutical Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Synflix Pharmaceutical Private Limited

Premium access

GST registrations and filing compliance for Synflix Pharmaceutical Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Synflix Pharmaceutical Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Synflix Pharmaceutical Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Synflix Pharmaceutical Private Limited

Premium access

MSME payment history for Synflix Pharmaceutical Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Synflix Pharmaceutical Private Limited

Premium access

Corporate group structure for Synflix Pharmaceutical Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Synflix Pharmaceutical Private Limited

Premium access

MCA filings and documents for Synflix Pharmaceutical Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Synflix Pharmaceutical Private Limited

Activity
30 Sep 2025
Synflix Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Synflix Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Directors
15 Feb 2018
Kannan Sudha was appointed as a Director on 15 Feb 2018 & has been associated with this company since 8 years 6 months.
Directors
15 Feb 2018
Arunachalam Lakshmi was appointed as a Director on 15 Feb 2018 & has been associated with this company since 8 years 6 months.
Activity
15 Feb 2018
Synflix Pharmaceutical Private Limited was registered on 15 Feb 2018 with Roc Chennai & aged 8 years 6 months as per MCA records.

Frequently Asked Questions about Synflix Pharmaceutical Private Limited

Synflix Pharmaceutical Private Limited is an active private limited company in the pharma sector based in Chennai, Tamil Nadu, India. It was incorporated on 15 February 2018 (8+ years old) and is registered under CIN U74999TN2018PTC120841.

Synflix Pharmaceutical Private Limited reported revenue of ₹63.52 Lakh for FY 2025 (up 139.00% YoY).

The current directors of Synflix Pharmaceutical Private Limited are:

The primary industry of Synflix Pharmaceutical Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Synflix Pharmaceutical Private Limited can be reached at the registered office: Plot No. 99 Sidco Industrial Estate Vichoor, Chennai, Tamil Nadu, India – 600103, or through the website synflixpharma.com.

The authorised capital is ₹50 Lakh, and the paid-up capital is ₹45 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available